G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells

Prostate

Volumn 71, Issue 12, 2011, Pages 1276-1286

  Liu, Jianjun ^a   Youn, Hyewon ^b,c   Yang, Jun ^c,d   Du, Ningchao ^a   Liu, Jihong ^d   Liu, Hongwei ^a   Li, Benyi ^a,c  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Seoul National University College of Medicine   (South Korea)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

androgen receptor; caveolae; G protein; prostate cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANDROGEN RECEPTOR; BROXURIDINE; CAVEOLIN 1; CAVEOLIN 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA12 SUBUNIT; LUCIFERASE; MESSENGER RNA; METHYL BETA CYCLODEXTRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P110BETA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CAVEOLA; CELL MEMBRANE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE DISRUPTION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; TRANSACTIVATION; WESTERN BLOTTING;

CAVEOLAE; CELL LINE, TUMOR; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; DNA; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; METRIBOLONE; PHOSPHATIDYLINOSITOL 3-KINASES; PROMOTER REGIONS, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 79960732692     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21345     Document Type: Article

References (40)

1. Scher HI, Sawyers CL,. Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005; 23: 8253-8261. (Pubitemid 46211563)
2. Heinlein CA, Chang C,. Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276-308. (Pubitemid 38501396)
3. Feldman BJ, Feldman D,. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45. (Pubitemid 33741879)
4. Edwards J, Bartlett JM,. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor. BJU Int 2005; 95: 1320-1326. (Pubitemid 40799454)
5. Daaka Y,. G proteins in cancer: The prostate cancer paradigm. Sci STKE 2004; 216: re2.
6. Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B,. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 2004; 145: 2941-2949. (Pubitemid 38686243)
7. Zhu Q, Youn H, Tang J, Tawfik O, Dennis K, Terranova PF, Du J, Raynal P, Thrasher JB, Li B,. Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers. Oncogene 2008; 27: 4569-4579.
8. Pi M, Spurney RF, Tu Q, Hinson T, Quarles LD,. Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor. Endocrinology 2002; 143: 3830-3838. (Pubitemid 35244362)
9. Lee SO, Lou W, Hou M, Onate SA, Gao AC,. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene 2003; 22: 7981-7988. (Pubitemid 37175863)
10. Franch HA, Wang X, Sooparb S, Brown NS, Du J,. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J Am Soc Nephrol 2002; 13: 903-909. (Pubitemid 34274086)
11. Chini B, Parenti M,. G-protein coupled receptors in lipid rafts and caveolae: How, when and why do they go there ? J Mol Endocrinol 2004; 32: 325-338. (Pubitemid 38584639)
12. Calaghan S, White E,. Caveolae modulate excitation-contraction coupling and beta2-adrenergic signaling in adult rat ventricular myocytes. Cardiovasc Res 2006; 69: 816-824. (Pubitemid 43227980)
13. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J, Thompson TC,. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 1998; 4: 1062-1064. (Pubitemid 28417340)
14. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP,. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005; 280: 25134-25145. (Pubitemid 40934606)
15. Pflug BR, Reiter RE, Nelson JB,. Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines. Prostate 1999; 40: 269-273. (Pubitemid 29398054)
16. Sowa G, Pypaert M, Fulton D, Sessa WC,. The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc Natl Acad Sci USA 2003; 100: 6511-6516. (Pubitemid 36666612)
17. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP,. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001; 276: 13442-13451.
18. Kasbohm EA, Guo R, Yowell CW, Bagchi G, Kelly P, Arora P, Casey PJ, Daaka Y,. Androgen receptor activation by G(s) signaling in prostate cancer cells. J Biol Chem 2005; 280: 11583-11589. (Pubitemid 40418471)
19. Bader AG, Kang S, Zhao L, Vogt PK,. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005; 5: 921-929. (Pubitemid 41766781)
20. Murga C, Laguinge L, Wetzker R, Cuadrado A, Gutkind JS,. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol- 3-OH kinasegamma. J Biol Chem 1998; 273: 19080-19085. (Pubitemid 28366302)
21. Evinger AJ III, Levin ER,. Requirements for estrogen receptor alpha membrane localization and function. Steroids 2005; 70: 361-363. (Pubitemid 40616033)
22. Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, De Falco A, Varricchio L, Bottero D, Nanayakkara M, Migliaccio A, Auricchio F,. Rapid signaling pathway activation by androgens in epithelial and stromal cells. Steroids 2004; 69: 517-522. (Pubitemid 39013481)
23. Heinlein CA, Chang C,. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 2002; 16: 2181-2187. (Pubitemid 35155532)
24. Gioeli D,. Signal transduction in prostate cancer progression. Clin Sci (Lond) 2005; 108: 293-308. (Pubitemid 40516993)
25. Culig Z,. Androgen receptor cross-talk with cell signaling pathways. Growth Factors 2004; 22: 179-184. (Pubitemid 39377910)
26. Nakhla AM, Leonard J, Hryb DJ, Rosner W,. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids 1999; 64: 213-216. (Pubitemid 29283674)
27. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA,. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 1999; 69: 481-485. (Pubitemid 29305572)
28. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA,. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids 1999; 64: 100-106. (Pubitemid 29168593)
29. Nazareth LV, Weigel NL,. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996; 271: 19900-19907. (Pubitemid 26281734)
30. Sadar MD,. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 1999; 274: 7777-7783.
31. Li S, Couet J, Lisanti MP,. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996; 271: 29182-29190. (Pubitemid 26382628)
32. Ozanne DM, Brady ME, Cook S, Gaughan L, Neal DE, Robson CN,. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol 2000; 14: 1618-1626.
33. Stahlhut M, van Deurs B,. Identification of filamin as a novel ligand for caveolin-1: Evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell 2000; 11: 325-337. (Pubitemid 30075526)
34. Sun M, Yang L, Feldman RI, Sun XM, Bhalla KN, Jove R, Nicosia SV, Cheng JQ,. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 2003; 278: 42992-43000. (Pubitemid 37345912)
35. Guo Z, Dai B, Jiang T, Xu K, Xie Y, Kim O, Nesheiwat I, Kong X, Melamed J, Handratta VD, Njar VC, Brodie AM, Yu LR, Veenstra TD, Chen H, Qiu Y,. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 2006; 10: 309-319. (Pubitemid 44512189)
36. Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL,. HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability. Cancer Cell 2004; 6: 517-527. (Pubitemid 39469987)
37. Schrantz N, da Silva Correia J, Fowler B, Ge Q, Sun Z, Bokoch GM,. Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling. J Biol Chem 2004; 279: 1922-1931. (Pubitemid 38084463)
38. Cha TL, Qiu L, Chen CT, Wen Y, Hung MC,. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res 2005; 65: 2287-2295. (Pubitemid 40490138)
39. Stephens L, Williams R, Hawkins P,. Phosphoinositide 3-kinases as drug targets in cancer. Curr Opin Pharmacol 2005; 5: 357-365. (Pubitemid 40932037)
40. Wettschureck N, Offermanns S,. Mammalian G proteins and their cell type specific functions. Physiol Rev 2005; 85: 1159-1204. (Pubitemid 41362268)